Public-domain · open source
OpenJurist

Md. Code Ann., Health Occ. § 14-509

Showing this section's text as in effect on January 1, 2020 (in force January 1, 2020 – January 1, 2021). View current text →

(a) In this section, “ACCME” means the Accrediting Council for Continuing Medical Education.

(b) A physician may dispense a topical medication that is approved by the federal Food and Drug Administration for the treatment of hypotichosis without obtaining a dispensing permit or completing the continuing education required under § 12–102(c)(2)(ii) of this article if the physician:

(1) Otherwise complies with the requirements of § 12–102(c)(2)(ii) of this article; and

(2) Has received a special class of written permit from the Board.

(c) The Board may issue a special class of written permit to a physician under subsection (b) of this section if the physician:

(1) Completes 1 hour of continuing medical education per year on the dispensing of topical medications developed by an ACCME–accredited Maryland nonprofit or governmental entity; and

(2) Pays to the Board a $100 permit fee.

Official source: Maryland General Assembly. Reproduced from public-domain Maryland statutes; confirm against the official source for the current text. Not legal advice.